Skip to content

Clinical trials

Terminated Phase 1/2 Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Phase 1/2 Status: Terminated Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20051
20061
20074
20086
20092
20104
20112
20121
20135
20143
20156
20163
20175
20184
20193
20202
20211
20221
20233
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated61

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center4
Incyte Corporation3
Masonic Cancer Center, University of Minnesota3
Alopexx Oncology, LLC2
Celgene2
Columbia University2
Jennifer Amengual2
Northwestern University2
Pfizer2
AHS Cancer Control Alberta1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma61
Lymphoma, Large B-Cell, Diffuse19
Leukemia18
Lymphoma, Non-Hodgkin18
Recurrence16
Lymphoma, Mantle-Cell13
Lymphoma, Follicular12
Multiple Myeloma11
Burkitt Lymphoma10
Lymphoma, B-Cell10

Trials

Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.